2D-BioPAD | Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease

Summary
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
Resources Show all and search (0)
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101120706
Start date: 01-10-2023
End date: 30-09-2027
Total budget - Public funding: 5 957 997,50 Euro - 5 957 949,00 Euro
Cordis data

Original description

2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).

Status

SIGNED

Call topic

HORIZON-CL4-2022-DIGITAL-EMERGING-02-19

Update Date

12-03-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.4 Digital, Industry and Space
HORIZON.2.4.0 Cross-cutting call topics
HORIZON-CL4-2022-DIGITAL-EMERGING-02
HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 2D materials-based devices and systems for biomedical applications (RIA)
HORIZON.2.4.3 Emerging enabling technologies
HORIZON-CL4-2022-DIGITAL-EMERGING-02
HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 2D materials-based devices and systems for biomedical applications (RIA)
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Organisations
Show all (11)
Powered by Chris Decubber BV